It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In 2015, the Zika virus (ZIKV) emerged in Brazil, leading to widespread outbreaks in Latin America. Following this, many countries in these regions reported a significant drop in the circulation of dengue virus (DENV), which resurged in 2018-2019. We examine age-specific incidence data to investigate changes in DENV epidemiology before and after the emergence of ZIKV. We observe that incidence of DENV was concentrated in younger individuals during resurgence compared to 2013-2015. This trend was more pronounced in Brazilian states that had experienced larger ZIKV outbreaks. Using a mathematical model, we show that ZIKV-induced cross-protection alone, often invoked to explain DENV decline across Latin America, cannot explain the observed age-shift without also assuming some form of disease enhancement. Our results suggest that a sudden accumulation of population-level immunity to ZIKV could suppress DENV and reduce the mean age of DENV incidence via both protective and disease-enhancing interactions.
Dengue virus circulation was unusually low in Brazil in 2015-2018 following the emergence of Zika virus, but subsequently resurged causing large outbreaks with a lower mean age of infection. Here, the authors use mathematical modelling to investigate the links between dengue dynamics and prior Zika infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Oxford, Department of Biology, Oxford, United Kingdom (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
2 Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Laboratório de Flavivírus, Rio de Janeiro, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931); Fundação Oswaldo Cruz, Instituto Rene Rachou, Belo Horizonte, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931); University of Campus Bio-Medico di Roma, Sciences and Technologies for Sustainable Development and One Health, Rome, Italy (GRID:grid.9657.d) (ISNI:0000 0004 1757 5329)
3 Universidade Estadual de Feira de Santana, Feira de Santana, Brazil (GRID:grid.412317.2) (ISNI:0000 0001 2325 7288)
4 Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Laboratório de Flavivírus, Rio de Janeiro, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931); Fundação Oswaldo Cruz, Instituto Rene Rachou, Belo Horizonte, Brazil (GRID:grid.418068.3) (ISNI:0000 0001 0723 0931)
5 University of Exeter, Centre for Ecology and Conservation, Penryn, United Kingdom (GRID:grid.8391.3) (ISNI:0000 0004 1936 8024); University of Tübingen, Institute for Tropical Medicine, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447)
6 Universidade Católica Portuguesa, Católica Biomedical Research, Católica Medical School, Lisbon, Portugal (GRID:grid.7831.d) (ISNI:0000 0001 0410 653X)